Investor profile
Golden Seeds
Angel syndicate
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Golden Seeds invests in early-stage, women-led U.S. companies with strong leadership, scalable models, and market potential. Typical rounds range from $250K–$2M, with valuations under $10M, across B2B & B2C technologies, health care, and consumer products or services. The firm's thesis rests on extensive research showing that gender-diverse teams produce better returns: companies in the top quartile for gender-diverse executive teams are 39% more likely to have above-average profitability (McKinsey, 2023), and women-founded companies generate 78 cents of revenue per dollar of funding versus 31 cents for male-founded companies. Founded in 2004 by a group of Wall Street women, Golden Seeds has grown into one of the largest angel networks in the U.S., with 9 chapters, 1,150+ investors, and over $200 million deployed into 275+ companies that have gone on to raise $2.5B+ in follow-on capital. The organization combines direct angel investing with member-managed venture funds (Golden Seeds Venture Fund and Golden Seeds Fund 2), investor education through the Knowledge Institute, and active post-investment support including board participation and introductions.
Notable quotes
“Fifteen years ago, when I first attended an Angel Capital Association meeting, 10% of attendees were women. Now it's 35% to 40%.”
“Women are getting levels of education, experience, and skills to be [angel investors and founders]. We are thrilled about that.”
“Angel investing is a team sport. Being part of a network of investors allows you to tap into the diversity and breadth of expertise within the group, which we feel substantially elevates the quality of due diligence.”
Team
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| EliseAI | Seed | — | — |
| Alcatraz AI | Series A | — | — |
| Work Truck Solutions | Seed | — | 2014-01-01 |
| Concerto Biosciences | Series A | $23m | — |
| Materna Medical | Series A | $22m | — |
| Brandwatch | Seed | — | — |
| PolyGone Systems | Seed | $5m | 2026-02-19 |
| Nullspace | Seed | $4m | 2025-08-19 |
| Avisi Technologies | Series A | $11m | 2026-02-26 |
| Osteoboost | Series A | $8m | 2026-04-15 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Astia | 5 |
| Fathom Fund | 3 |
| Fyrfly Venture Partners | 2 |
| Mutual Capital Partners | 2 |
| MedVenture Partners | 2 |
| Fall Line Capital | 2 |
Fit check
Is Golden Seeds a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit